Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome

References

• Speroff L, Fritz M. Clinical gynecologic endocrinology and infertility. 7th ed. New York, NY: Lippincott Williams & Wilkins; 2005:485–513
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• ESHRE Capri Workshop Group. Mono-ovulatory cycles: a key goal in profertility programmes. Hum Reprod Update 2003;9:263–74
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685–718
   PubMed Web of Science ®Google Scholar
• Devroey P, Fauser BC, Diedrich K; Evian Annual Reproduction (EVAR) Workshop Group 2008. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2009;15:391–408
   PubMed Web of Science ®Google Scholar
• Roudebush WE, Kivens WJ, Mattke JM. Biomarkers of ovarian reserve. Biomark Insights 2008;3:259–68
   PubMedGoogle Scholar
• La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol 2006;64:603–10
   PubMed Web of Science ®Google Scholar
• Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006;131:1–9
   PubMed Web of Science ®Google Scholar
• Karkanaki A, Vosnakis C, Panidis D. The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology. Hormones 2011;10:95–103
   PubMedGoogle Scholar
• Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505–14
   PubMed Web of Science ®Google Scholar
• Fréour T, Mirallié S, Bach-Ngohou K, et al. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chem Acta 2007;375:162–4
   PubMed Web of Science ®Google Scholar
• Babson AL. The Cirrus IMMULITE automated immunoassay system. J Clin Immunoassay 1991;14:84–8
   Google Scholar
• Fallat ME, Siow Y, Marra M, et al. Müllerian inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome and endometriosis. Fertil Steril 1997;67:962–5
   PubMed Web of Science ®Google Scholar
• Cook C, Siow Y, Bremer AG, Fallat ME. Relation between Müllerian inhibiting substance and other reproductive hormones in untreated women with PCOS and normal women. Fertil Steril 2002;77:141–6
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of AMH in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957–62
   PubMed Web of Science ®Google Scholar
• Laven JS, Mulders AG, Visser JA, et al. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89:318–23
   PubMed Web of Science ®Google Scholar
• Begawy AF, El-Mazny AN, Abou-Salem NA, El-Taweel NE. Anti-Müllerian hormone in polycystic ovary syndrome and normo-ovulatory women: correlation with clinical, hormonal and ultrasonographic parameters. Middle East Fertil Soc J 2010;15:253–8
   Google Scholar
• Pigny P, Jonard S, Robert Y, Dewailly D. Serum AMH as a surrogate for antral follicle count for definition of polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:941–5
   PubMed Web of Science ®Google Scholar
• Grossman M, Nakajima S, Fallat M, Siow Y. Müllerian inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 2008;89:1364–70
   PubMed Web of Science ®Google Scholar
• El-Halawaty S, Rizk A, Kamal M, et al. Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome. Reprod Biomed Online 2007;15:495–9
   PubMed Web of Science ®Google Scholar
• Amer SA, Li TC, Ledger WL. The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy. Hum Reprod 2009;24:2760–6
   PubMed Web of Science ®Google Scholar
• Seifer DB, MacLaughlin DT, Christian BP, et al. Early follicular serum Mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468–71
   PubMed Web of Science ®Google Scholar
• Nardo LG, Gelbaya TA, Wilkinson H, et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 2009;92:1586–93
   PubMed Web of Science ®Google Scholar
• Broer S, Mol BW, Dolleman M, et al. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010;22:193–201
   PubMed Web of Science ®Google Scholar
• Nakhuda GS, Chu MC, Wang J, et al. Elevated serum MIS levels may be a marker for ovarian hyperstimulation syndrome in normal women undergoing IVF. Fertil Steril 2006;85:1541–3
   PubMed Web of Science ®Google Scholar